Stereotactic body radiation therapy for stage I non-small cell lung carcinomas: Moderate hypofractionation optimizes outcome.
Fiche publication
Date publication
décembre 2018
Journal
Lung cancer (Amsterdam, Netherlands)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine, Pr NOEL Georges
Tous les auteurs :
Menoux I, Antoni D, Truntzer P, Keller A, Massard G, Noël G
Lien Pubmed
Résumé
In case of inoperability or refusal of surgery, stereotactic body radiation therapy (SBRT) is the most effective treatment for a stage I non-small cell lung carcinoma (NSCLC). The results obtained by this irradiation technique are considerably superior to those observed in the time of conventional 3D irradiation and its toxicities are much less important, which makes it possible in elderly patients, or those presenting cardio-pulmonary comorbidities and a poor perfomance status.
Mots clés
Efficiency, Non-small cell lung carcinoma, Prognostic factor, Radiation pneumonitis, Stage I lung carcinoma, Stereotactic
Référence
Lung Cancer. 2018 Dec;126:201-207